STOCK TITAN

AMETEK sells $500M, C$600M and €1.5B in senior notes

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

AMETEK, Inc. completed sales of $500 million of 5.550% Senior Notes due November 20, 2031, C$600 million of 4.500% Senior Notes due November 20, 2032, and €1.5 billion of EUR Senior Notes: €750 million of 4.150% notes due November 20, 2030, and €750 million of 4.450% notes due November 20, 2034.

USD and CAD interest is payable semiannually on May 20 and November 20, beginning May 20, 2027; EUR interest is payable annually on November 20, beginning November 20, 2027. The notes are unsecured and unsubordinated, rank equally in right of payment with AMETEK’s existing and future unsecured and unsubordinated debt, and are effectively subordinated to subsidiary indebtedness and other liabilities, including trade payables. The indenture restricts certain liens, sale-and-leaseback transactions, mergers, and transfers of substantially all assets, subject to qualifications and exceptions.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Principal amount $500 million 5.550% USD Senior Notes due November 20, 2031
Interest rate 5.550% USD Senior Notes due November 20, 2031
Principal amount C$600 million 4.500% CAD Senior Notes due November 20, 2032
Interest rate 4.500% CAD Senior Notes due November 20, 2032
Principal amount €750 million 4.150% EUR Senior Notes due November 20, 2030
Interest rate 4.150% EUR Senior Notes due November 20, 2030
Principal amount €750 million 4.450% EUR Senior Notes due November 20, 2034
Interest rate 4.450% EUR Senior Notes due November 20, 2034
make-whole redemption price financial
"at a “make-whole” redemption price"
The make-whole redemption price is the amount an issuer pays to buy back debt early that compensates bondholders for the interest they will miss out on. It is usually calculated by taking the present value of the remaining scheduled payments, discounted at a specified rate (often a Treasury yield plus a spread), sometimes with a small premium — like refunding a prepaid service by reimbursing the remaining value today. It matters because it determines how much bondholders receive if the debt is called and affects the issuer’s cost of early repayment.
unsecured and unsubordinated obligations financial
"The Notes are unsecured and unsubordinated obligations"
effectively subordinated financial
"the Notes are effectively subordinated to all indebtedness"
Debt or claims that are not legally listed as lower priority but, in practice, will be paid after other creditors because of the company’s structure or secured claims. Think of it like standing behind people who are already in line: even if your ticket says you’re next, the way the lines are organized means others get served first, so your chance of getting paid in a default is reduced accordingly.
sale and leaseback transactions financial
"to enter into sale and leaseback transactions"
events of default financial
"The Indenture provides for certain events of default"
Events of default are specific breaches or failures listed in a loan, bond, or credit agreement that give lenders the right to act, such as demanding immediate repayment, raising interest rates, or taking secured assets. They matter to investors because triggering one is like setting off a financial alarm: it raises the chance of foreclosure, restructuring, or bankruptcy and can sharply reduce the value of a company’s stock or bonds and increase borrowing costs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much in notes did AMETEK (AME) sell?

AMETEK completed sales of $500 million in USD notes, C$600 million in CAD notes, and €1.5 billion in EUR notes. The EUR amount comprises €750 million of notes due in 2030 and €750 million due in 2034.

What are the interest rates and maturities of AMETEK’s (AME) new notes?

The notes carry rates of 5.550% on USD notes due November 20, 2031; 4.500% on CAD notes due November 20, 2032; and 4.150% and 4.450% on EUR notes due November 20, 2030 and November 20, 2034, respectively.

When can AMETEK redeem the notes before maturity?

AMETEK may redeem the USD notes before October 20, 2031, the CAD notes before September 20, 2032, the EUR 2030 notes before October 20, 2030, and the EUR 2034 notes before August 20, 2034, at the applicable make-whole price. On or after each date, redemption may be at 100% of principal, plus accrued and unpaid interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001037868 0001037868 2026-11-20 2026-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 20, 2026

 

 

 

AMETEK, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Commission File Number: 1-12981

 

Delaware   14-1682544
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
1100 Cassatt Road Berwyn PA   19312
(Address of principal executive offices)   (Zip Code)

 

(610) 647-2121

(Registrant’s telephone number, including area code) 

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of exchange on which registered
Common Stock, $0.01 Par Value (voting) AME New York Stock Exchange (NYSE)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

USD Notes

 

On November 20, 2026, AMETEK, Inc. (the “Company”) completed the sale of $500,000,000 aggregate principal amount of the Company’s 5.550% Senior Notes due 2031 (the “USD Notes”).

 

The USD Notes bear interest at a rate of 5.550% per year, payable semiannually in arrears on May 20 and November 20 of each year, beginning on May 20, 2027. The USD Notes will mature on November 20, 2031, unless earlier redeemed or repurchased. The Company may redeem the USD Notes, in whole or in part, at any time prior to October 20, 2031 at a “make-whole” redemption price set forth in the First Supplemental Indenture (which redemption price may not be less than the principal amount of the USD Notes to be redeemed) and at any time on or after October 20, 2031 at 100% of the principal amount, in each case, plus accrued and unpaid interest, if any, to the date of redemption.

 

CAD Notes

 

On November 20, 2026, the Company completed the sale of C$600,000,000 aggregate principal amount of the Company’s 4.500% Senior Notes due 2032 (the “CAD Notes”).

 

The CAD Notes bear interest at a rate of 4.500% per year, payable semiannually in arrears on May 20 and November 20 of each year, beginning on May 20, 2027. The CAD Notes will mature on November 20, 2032, unless earlier redeemed or repurchased. The Company may redeem the CAD Notes, in whole or in part, at any time prior to September 20, 2032 at a “make-whole” redemption price set forth in the Third Supplemental Indenture (which redemption price may not be less than the principal amount of the CAD Notes to be redeemed) and at any time on or after September 20, 2032 at 100% of the principal amount, in each case, plus accrued and unpaid interest, if any, to the date of redemption.

 

EUR Notes

 

On November 20, 2026, the Company completed the sale of €1,500,000,000 aggregate principal amount of the Company’s EUR Notes as follows: €750,000,000 aggregate principal amount of the Company’s 4.150% Senior Notes due 2030 (the “EUR 2030 Notes”) and €750,000,000 aggregate principal amount of the Company’s 4.450% Senior Notes due 2034 (the “EUR 2034 Notes” and, together with the EUR 2030 Notes, the “EUR Notes”).

 

The EUR 2030 Notes bear interest at a rate of 4.150% per year, payable annually in arrears on November 20 of each year, beginning on November 20, 2027. The EUR 2030 Notes will mature on November 20, 2030, unless earlier redeemed or repurchased. The Company may redeem the EUR 2030 Notes, in whole or in part, at any time prior to October 20, 2030 at a “make-whole” redemption price set forth in the Second Supplemental Indenture (which redemption price may not be less than the principal amount of the EUR 2030 Notes to be redeemed) and at any time on or after October 20, 2030 at 100% of the principal amount, in each case, plus accrued and unpaid interest, if any, to the date of redemption.

 

 

 

 

The EUR 2034 Notes bear interest at a rate of 4.450% per year, payable annually in arrears on November 20 of each year, beginning on November 20, 2027. The EUR 2034 Notes will mature on November 20, 2034, unless earlier redeemed or repurchased. The Company may redeem the EUR 2034 Notes, in whole or in part, at any time prior to August 20, 2034 at a “make-whole” redemption price set forth in the Second Supplemental Indenture (which redemption price may not be less than the principal amount of the EUR 2034 Notes to be redeemed) and at any time on or after August 20, 2034 at 100% of the principal amount, in each case, plus accrued and unpaid interest, if any, to the date of redemption.

 

Indenture

 

The USD Notes, CAD Notes and EUR Notes are referred to collectively as the “Notes”. The Notes were issued under and are governed by an Indenture, dated as of November 10, 2026 (the “Base Indenture”), by and between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented and amended by a First Supplemental Indenture, dated as of November 20, 2026, by and between the Company and the Trustee (the “First Supplemental Indenture”), a Second Supplemental Indenture, dated as of November 20, 2026, by and between the Company and the Trustee (the “Second Supplemental Indenture”) and a Third Supplemental Indenture, dated as of November 20, 2026, by and between the Company and the Trustee (the “Third Supplemental Indenture” and, together with the Second Supplemental Indenture, the First Supplemental Indenture and the Base Indenture, the “Indenture”).

 

The Notes are unsecured and unsubordinated obligations of the Company. The Notes rank equal in right of payment with all of the Company’s existing and future unsecured and unsubordinated indebtedness and the Notes are effectively subordinated to all indebtedness and other liabilities, including trade payables, of the Company’s subsidiaries.

 

Subject to a number of important qualifications and exceptions, the Indenture, among other things, limits the Company’s ability and the ability of the Company’s restricted subsidiaries to create liens and to enter into sale and leaseback transactions and limit the Company’s ability to merge or consolidate with or into other entities or to sell, lease or convey all or substantially all of the Company’s and its restricted subsidiaries’ assets, taken as a whole.

 

The Indenture provides for certain events of default which include (subject in certain cases to grace and cure periods), among others, nonpayment of principal or interest; breach of covenants or warranties in the Indenture; defaults under or failure to pay certain other indebtedness; failure to pay certain final judgments; and certain events of bankruptcy, insolvency, reorganization, administration or similar proceedings.

 

The foregoing is a brief description of certain terms of the Indenture and, by its nature, is incomplete. It is qualified in its entirety by the text of the Indenture. The Company is filing the First Supplemental Indenture as Exhibit 4.2, Second Supplemental Indenture as Exhibit 4.3 and Third Supplemental Indenture as Exhibit 4.4 to this Current Report on Form 8-K, and has filed the Base Indenture with the Securities and Exchange Commission on November 10, 2026 as Exhibit 4.8 to the Company’s Registration Statement on Form S-3, all of which are incorporated herein by reference.

 

 

 

 

Item 8.01. Other Events.

 

The legal opinion of Morgan, Lewis & Bockius LLP as to the validity of the Notes is attached as Exhibit 5.1 to this Current Report on Form 8-K and such opinion contains the consent of Morgan, Lewis & Bockius LLP to the filing of its opinion as an exhibit to this Current Report on Form 8-K.

 

Forward-Looking Statements

 

Certain of the statements contained in this Current Report on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”). Words such as “aim,” “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “on track,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “strive,” “sustain,” “synergy,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. These statements are not guarantees of future performance and are based on assumptions and estimates that could prove incorrect or could cause actual results to vary materially from those indicated. A more detailed discussion of the risks and uncertainties that could cause the Company’s actual results to differ materially from those indicated is included in the “Risk Factors” and “Management’s Discussion and Analysis” sections in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and elsewhere in that report and other reports filed by the Company pursuant to the Securities Exchange Act. The Company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by the federal securities laws.

 

 

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit
Number
  Description
   
4.1   Indenture, dated as of November 10, 2026, between AMETEK, Inc. and U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.8 to the Company’s Registration Statement on Form S-3 filed November 10, 2026, and incorporated by reference herein).
4.2   First Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note).
4.3   Second Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note).
4.4   Third Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note).
5.1   Opinion of Morgan, Lewis & Bockius LLP.
23.1   Consent of Morgan, Lewis & Bockius LLP (contained in Exhibit 5.1).
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AMETEK, Inc.
     
November 20, 2026 By: /s/ ROBERT J. AMODEI
    Name: Robert J. Amodei
    Title: Senior Vice President – Controller

 

 

 

 

Filing Exhibits & Attachments

7 documents

Keep reading